Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer.

MLA

Kim, R. D., et al. “Phase I Dose-Escalation Study of Copanlisib in Combination with Gemcitabine or Cisplatin plus Gemcitabine in Patients with Advanced Cancer.” British Journal of Cancer, vol. 118, no. 4, Feb. 2018, pp. 462–70. EBSCOhost, https://doi.org/10.1038/bjc.2017.428.

APA

Kim, R. D., Alberts, S. R., Peña, C., Genvresse, I., Ajavon-Hartmann, A., Xia, C., Kelly, A., Grilley-Olson, J. E., & Peña, C. (2018). Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer. British Journal of Cancer, 118(4), 462–470. https://doi.org/10.1038/bjc.2017.428

Chicago

Kim, R D, S R Alberts, C Peña, I Genvresse, A Ajavon-Hartmann, C Xia, A Kelly, J E Grilley-Olson, and C Peña. 2018. “Phase I Dose-Escalation Study of Copanlisib in Combination with Gemcitabine or Cisplatin plus Gemcitabine in Patients with Advanced Cancer.” British Journal of Cancer 118 (4): 462–70. doi:10.1038/bjc.2017.428.